Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable/Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03817125
What this trial is testing

Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention

Who this might be right for
Metastatic Melanoma
Parker Institute for Cancer Immunotherapy 14
Not applicableStudy completedNCT02975700
What this trial is testing

PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma

Who this might be right for
Melanoma
Daiichi Sankyo Co., Ltd. 6
Early research (Phase 1)Study completedNCT02138292
What this trial is testing

A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma

Who this might be right for
Melanoma
University of Texas Southwestern Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT02392871
What this trial is testing

Radiotherapy & Combi in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Melanoma and Skin Cancer Trials Limited 10
Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT01168050
What this trial is testing

Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.

Who this might be right for
Malignant Skin Melanoma T0Stage III MelanomaStage IV Melanoma+1 more
Assistance Publique - Hôpitaux de Paris 25
Early research (Phase 1)Looking for participantsNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Early research (Phase 1)Study completedNCT03159117
What this trial is testing

Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00706238
What this trial is testing

MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline 5
Early research (Phase 1)WithdrawnNCT05717140
What this trial is testing

Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the LungMetastatic Melanoma+2 more
Mayo Clinic
Early research (Phase 1)Study completedNCT02983006
What this trial is testing

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 12
Large-scale testing (Phase 3)Ended earlyNCT02967692
What this trial is testing

The Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 568
Large-scale testing (Phase 3)Study completedNCT02905266
What this trial is testing

A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817901
What this trial is testing

Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Yonsei University 46
Not applicableStudy completedNCT02492815
What this trial is testing

PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,773
Testing effectiveness (Phase 2)Looking for participantsNCT06284590
What this trial is testing

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Philogen S.p.A. 162
Large-scale testing (Phase 3)Not Yet RecruitingNCT07815574
What this trial is testing

ISCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma

Who this might be right for
Melanoma (Skin Cancer)Advanced MelanomaMetastatic Melanoma+1 more
Scancell Ltd 550
Testing effectiveness (Phase 2)Ended earlyNCT02314143
What this trial is testing

Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib

Who this might be right for
Melanoma
GlaxoSmithKline 48
Large-scale testing (Phase 3)Study completedNCT02714218
What this trial is testing

Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 387
Early research (Phase 1)Study completedNCT03021460
What this trial is testing

Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+4 more
Mayo Clinic 20
Next Page
150